Prof. Dr. rer. nat. Helge Taubert



Organisationseinheit


Urologische Klinik
Professur für Molekulare Urologie


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 6 Go to next page Go to last page

Wach, S., Brandl, M., Borchardt, H., Weigelt, K., Lukat, S., Nolte, E.,... Aigner, A. (2019). Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo. Molecular Therapy - Nucleic Acids, 16, 272-283. https://dx.doi.org/10.1016/j.omtn.2019.02.020
Eckstein, M., Erben, P., Kriegmair, M.C., Worst, T.S., Weiss, C.-A., Wirtz, R.M.,... Erlmeier, F. (2019). Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. European journal of cancer, 106, 234-243. https://dx.doi.org/10.1016/j.ejca.2018.11.007
Stoehr, C.G., Steffens, S., Polifka, I., Jung, R., Kahlmeyer, A., Ivanyi, P.,... Taubert, H. (2019). Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients. Scientific Reports, 9. https://dx.doi.org/10.1038/s41598-018-38254-3
Rot, S., Kaune, T., Taubert, H., Greither, T., Kotrba, J., Guettler, A.,... Kappler, M. (2019). Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients. BMC Cancer, 19. https://dx.doi.org/10.1186/s12885-019-5327-8
Tsaur, I., Hüsch, T., Jüngel, E., Schneider, F., Schneider, M., Haferkamp, A.,... Blaheta, R.A. (2019). sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitro. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2019.03.001
Taubert, H., Becker, C., Borkowetz, A., Seitz, G., Kristiansen, G., Wach, S., & Wullich, B. (2018). 15th annual conference of the DPKK. Urologe, 57(8), 966-968. https://dx.doi.org/10.1007/s00120-018-0710-7
Eckstein, M., Wirtz, R., Pfannstil, C., Wach, S., Stoehr, R., Breyer, J.,... Erben, P. (2018). A multicenter comparison of PD-L1 protein and mRNA expression in urothelial bladder cancer by immunohistochemistry and RT-qPCR (Checkpoint-Typer(C)): A round robin test by the BRIDGE-Consortium Germany. (pp. 81-81).
Eckstein, M., Wirtz, R.M., Pfannstil, C., Wach, S., Stoehr, R., Breyer, J.,... Erben, P. (2018). A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy. Oncotarget, 9(19), 15001-15014. https://dx.doi.org/10.18632/oncotarget.24531
Silva, I.T., Munkert, J., Nolte, E., Schneider, N.F.Z., Rocha, S.C., Ramos, A.C.P.,... Simões, C.M.O. (2018). Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na+/K+ -ATPase inhibition. Biomedicine & Pharmacotherapy, 107, 464-474. https://dx.doi.org/10.1016/j.biopha.2018.08.028
Wach, S., Weigelt, K., Michalke, B., Lieb, V., Stoehr, R., Keck, B.,... Chaudhri, A. (2018). Diagnostic potential of major and trace elements in the serum of bladder cancer patients. Journal of Trace Elements in Medicine and Biology, 46, 150-155. https://dx.doi.org/10.1016/j.jtemb.2017.12.010

Zuletzt aktualisiert 2017-16-10 um 02:00